Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

BLU

BELLUS Health (BLU)

BELLUS Health Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:BLU
日付受信時刻ニュースソース見出しコード企業名
2024/01/3100 : 56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLUBELLUS Health Inc
2023/08/1506 : 01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLUBELLUS Health Inc
2023/07/1021 : 00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BLUBELLUS Health Inc
2023/06/2906 : 22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BLUBELLUS Health Inc
2023/06/2906 : 21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
2023/06/2906 : 21Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BLUBELLUS Health Inc
2023/06/2906 : 20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
2023/06/2905 : 57Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
2023/06/2905 : 11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BLUBELLUS Health Inc
2023/06/2905 : 10Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:BLUBELLUS Health Inc
2023/06/2903 : 42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLUBELLUS Health Inc
2023/06/2900 : 06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/06/2900 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLUBELLUS Health Inc
2023/06/2823 : 59PR Newswire (Canada)Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS SantéNASDAQ:BLUBELLUS Health Inc
2023/06/2823 : 57PR Newswire (Canada)Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS HealthNASDAQ:BLUBELLUS Health Inc
2023/06/1702 : 50Business WireBELLUS Health Inc. Announces Voting Results from Special Meeting of ShareholdersNASDAQ:BLUBELLUS Health Inc
2023/06/1702 : 50Business WireBELLUS Santé inc. annonce les résultats du vote tenu à l’assemblée extraordinaire des actionnairesNASDAQ:BLUBELLUS Health Inc
2023/06/0705 : 07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/2006 : 28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/1706 : 05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/1706 : 01Business WireBELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK AcquisitionNASDAQ:BLUBELLUS Health Inc
2023/05/1706 : 01Business WireBELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSKNASDAQ:BLUBELLUS Health Inc
2023/05/1305 : 33Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/1305 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/1305 : 01Business WireBELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023NASDAQ:BLUBELLUS Health Inc
2023/05/1305 : 01Business WireBELLUS Health Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:BLUBELLUS Health Inc
2023/04/2900 : 14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/04/2719 : 07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/04/2719 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/04/2707 : 00Business WireBELLUS Health Announces Meeting UpdatesNASDAQ:BLUBELLUS Health Inc
 Showing the most relevant articles for your search:NASDAQ:BLU